N@N

BioElectronics and Unior Bionic Expand Eastern European Distribution

^{Published on 2010-07-08 06:12:57 - Market Wire}
 

FREDERICK, MD--(Marketwire - July 8, 2010) - BioElectronics Corporation (PINKSHEETS: [ BIEL ]), manufacturers of innovative pain-relieving medical devices, announced today that it is developing additional markets in Eastern Europe for its clinically-proven ActiPatch, Recovery Rx and Allay Menstrual Relief brands through an expansion of its distribution agreement with Unior Bionic d.o.o.

"This market expansion adds the Ukraine, Czech Republic, Poland and Hungary to their markets and represents a major milestone in our product availability throughout Eastern Europe," said Arnon Horev, BioElectronics' Vice President of Sales and Marketing.

Unior Bionic is a division of Unior, [ www.unior.com ], one of the largest diversified Eastern European manufacturers and sales organization. The medical division, Unior Bionic, develops, manufactures and distributes medical products throughout the Eastern European market.

BioElectronics Corporation (PINKSHEETS: BIEL) is the maker of safe, inexpensive, drug-free medical devices. The company's wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch™, RecoveryRx™, Allay™ Menstrual Pain Therapy and HealFast™ Therapy for cats, dogs and horses. The company is headquartered in Frederick, MD. For more information, visit [ www.bielcorp.com ].